Navigation Links
Genta Announces Second Quarter 2008 Financial Results and Conference Call
Date:7/31/2008

BERKELEY HEIGHTS, N.J., July 31 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced today that the Company will release its second quarter 2008 financial results on Thursday, August 7, 2008. Genta management will host a conference call and live audio webcast to discuss these financial results and corporate activities at 8:00 am EDT.

Participants can access the live call by dialing (877) 634-8606 (U.S. and Canada) or (706) 679-3140 (International). The access code for the live call is Genta Incorporated. The call will also be webcast live at http://www.genta.com/investorrelation/events.html

For investors unable to participate in the live call, a replay will be available approximately two hours after the completion of the call, and will be archived for 30 days. Access numbers for this replay are: (800) 642-1687 (U.S. and Canada) and (706) 645-9291 (International); conference ID number is 57549066.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment fo
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
2. Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
3. Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
4. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
5. Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
6. Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board
7. Dr. Elizabeth Brown Joins Argenta TEC
8. Syngenta To Build Major Global Biotech Research Center in Beijing, China
9. Genta Restructures Operations to Focus on Priority Initiatives
10. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
11. Auditors for Genta Incorporated Express Going Concern Qualification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... TORONTO , Sept. 22, 2014 ... announced that it has entered into a collaboration ... UHN,s Centre for Molecular Design and Preformulations (CMDP) ... The goal of the project is to increase ... proprietary buccal insulin spray product, thereby reducing the ...
(Date:9/22/2014)... 2014 METTLER TOLEDO is pleased ... measuring device CNS110 ScanTape™ . Replacing a ... offering greater ease and accuracy for transport and ... significantly enhance productivity—an important benefit for load planning ... equals profits. , Usable at any point ...
(Date:9/21/2014)... Chemical Sciences play a significant ... clean air and safe water, healthy food, and ... environmentalists, food scientists, educators, and scientists have a ... field of Chemistry for the national development, and ... of the fastest emerging Sciences, accelerating with a ...
(Date:9/19/2014)... is rarely simple. From crop yields to disease risks, ... those considered "complex traits." Just as for heightthe textbook ... particular human disease are shaped by multiple genetic and ... involved. To track down such genes, geneticists typically mate ... large mouse and a small mouseand then study their ...
Breaking Biology Technology:Generex Collaborates with University Health Network for Buccal Insulin Project 2Generex Collaborates with University Health Network for Buccal Insulin Project 3Generex Collaborates with University Health Network for Buccal Insulin Project 4ScanTape™ Handheld Dimensioner Increases Processing Volume 2Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3Want to link genes to complex traits? Start with more diversity 2
... Pharmaceuticals Inc., a,drug discovery and development company, is ... J. Cohen as Vice President, Discovery Research., ... Xenon team," commented,Simon Pimstone, Xenon,s President and CEO. ... and leadership including in areas,that are highly relevant ...
... (Nasdaq: ANDS ) announced today that it will ... on Tuesday, February 12, 2008 at 2:45 p.m.,EST (11:45 ... Waldorf-Astoria,Hotel in New York., Steve Worland, Ph.D., President ... an overview of Anadys and its two,development-stage product candidates, ...
... hereby given,that Finkelstein Thompson LLP has filed a Class ... Western District of Washington on,behalf of a class (the ... otherwise acquired the common stock of CellCyte Genetics,Corporation ("CellCyte" ... 2007 and January 9, 2008 inclusive (the "Class Period")., ...
Cached Biology Technology:Xenon Announces Appointment of VP, Discovery Research 2Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference 2Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation 2
(Date:9/19/2014)... for the sake of fairness per se but in ... say Frans de Waal, PhD, and Sarah Brosnan, PhD, ... which is defined as a negative reaction to unequal ... , Their conclusion comes after the co-authors reviewed ... that it is the evolution of forestalling partner dissatisfaction ...
(Date:9/19/2014)... Inc. (Nasdaq: NXTD and NXTDW) ("Nxt-ID" or the ... updates the "Wocket in Your Pocket" celebrity ad campaign, featuring former ... classes, Vinny Pazienza (PAZ). , ... actor Ciaran Hinds and Sons of Anarchy ... have been cast in Bleed for This . ...
(Date:9/18/2014)... University researchers have developed a unique method to use ... in rural areas. , The first microbe-powered, self-sustaining ... quick way to clean up waste from large farming ... , Professor Haluk Beyenal and graduate student Timothy ... discuss the system in the online edition of ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3Researchers develop unique waste cleanup for rural areas 2
... the qualitative description of evolution its observed behavior ... that captures general evolution dynamics is still lacking. There ... life on Earth, including the question of why sex ... scientists from the Chinese Academy of Sciences; Jilin University ...
... the year drought has been plaguing American grasslands. But a ... losing the turf war against climate when it comes to ... looked at the drought tolerance of 426 species of grass ... how grasslands in different parts of the world may respond ...
... of the car; it is difficult to make out anything in ... and onto the road, but the driver cannot respond in time. ... of "extending" the human eye and defusing such dangerous situations. They ... a living creature and in case of danger, warn the ...
Cached Biology News:Physics and math shed new light on biology by mapping the landscape of evolution 2Diversity keeps grasslands resilient to drought, climate change 2Diversity keeps grasslands resilient to drought, climate change 3Cost-effective production of infrared lenses 2
... dispenser combining the most versatile features for bulk ... existing Multidrop dispensers. , ,It is designed ... nl up to 2500 l with excellent precision ... for multiple plate formats (96, 384, 1536) including ...
... Multidrop Combi is a new generation bulk ... flexibility and simplicity for pharmaceutical and biotech ... reliable Multidrop range, Multidrop Combi has been ... volumes of 0.5-2500 l and multiple plate ...
Multidrop DW is a high-speed automated dispenser for Deep Well plates, 1.1 ml test tubes and 96-well plates. Designed for accuracy and precision, the Multidrop DW dispenses up to eight different reag...
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
Biology Products: